Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids.
D000818:Animals; D000873:Anthracenes / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000378:metabolism*; D001665:Binding Sites; D002467:Cell Nucleus / Q000378:metabolism; D006224:Cricetinae; D003593:Cytoplasm / Q000378:metabolism; D004273:DNA, Neoplasm / Q000378:metabolism*; D004563:Electrochemistry; D066298:In Vitro Techniques; D007942:Leukemia, Experimental / Q000378:metabolism; D051379:Mice; D008942:Mitoxantrone; D012334:RNA, Neoplasm / Q000378:metabolism*; D013053:Spectrophotometry; D013816:Thermodynamics
D000873:Anthracenes; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D008942:Mitoxantrone